Executive Director, Head Digital, Data, Analytics and Performance

We are looking for an innovative, driven and creative Executive Director, Head Digital, Data, Analytics and Performance to join our team at Glaxo Smith Kline (GSK). The successful candidate will be responsible for leading and managing a team of digital, data, analytics and performance experts to ensure GSK’s business success. This is a highly visible, strategic role that requires excellent business acumen, a passion for data, and the ability to think outside of the box. The successful candidate must have a degree in computer science, engineering, or related field, with a minimum of 8 years of experience in a digital, data, analytics and performance role. The ideal candidate should have excellent communication, problem-solving and organizational skills, as well as a deep understanding of data-driven technologies, processes, and methodologies. A proven track record in leading, developing, and coaching a team is essential, as is a strong understanding of the commercial implications of digital, data, analytics and performance. We are looking for an individual who is passionate about data, analytics and performance, and is committed to driving GSK’s digital transformation. The successful candidate must have the ability to think strategically and innovate tactically, and be able to develop and implement creative solutions to complex business challenges. We are looking for someone who is excited by the opportunity to join a world-class team and make a real impact.

According to JobzMall, the average salary range for a Executive Director, Head Digital, Data, Analytics and Performance in Collegeville, PA 19426, USA is $127,000 - $168,000. This range can vary depending on the individual's experience, qualifications, and other factors.

GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth largest pharmaceutical company as of 2015, after Pfizer, Novartis, Merck, Hoffmann-La Roche and Sanofi.